BROOKS LABORATORIES LTD.

NSE : BROOKSBSE : 533543ISIN CODE : INE650L01011Industry : Pharmaceuticals & DrugsHouse : Private
BSE92.80-1.5 (-1.59 %)
PREV CLOSE ( ) 94.30
OPEN PRICE ( ) 98.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 23265
TODAY'S LOW / HIGH ( )91.30 98.10
52 WK LOW / HIGH ( )56.5 185.15
NSE93.60-1.95 (-2.04 %)
PREV CLOSE( ) 95.55
OPEN PRICE ( ) 96.05
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 53639
TODAY'S LOW / HIGH( ) 92.00 98.80
52 WK LOW / HIGH ( )56.95 185.7
( in Million)
Select year
ParticularsMar2023Mar2022Mar2021
Profit Before Tax-354.25-238.98-89.93
Adjustment96.91110.47102.90
Changes In working Capital113.96-243.2773.66
Cash Flow after changes in Working Capital-143.38-371.7886.62
Cash Flow from Operating Activities-144.90-374.4144.59
Cash Flow from Investing Activities4.95-249.09-51.30
Cash Flow from Financing Activities114.14640.7111.59
Net Cash Inflow / Outflow-25.8217.214.88
Opening Cash & Cash Equivalents26.058.843.96
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANANA
Effect of Foreign Exchange FluctuationsNANANA
Closing Cash & Cash Equivalent0.2326.058.84

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.